This is a disclosure report regarding direct/indirect conflicts of interest of a financial, functional or any other nature related to commercial and non-commercial organizations.
Commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature:
- Scientific Advisory Boards (my institution, no personal gain): Duke Street Bio, Eisai, Ellipses, Grey Wolf Therapeutics, MSD, Roche
- Independent Safety/Data Monitoring Boards (*honorarium): Exscientia/Recursion*, WCG/Valley Hospital*, University of Oxford, Institute of Cancer Research / Royal Marsden Hospital
- Speaker (honorarium): Ipsen
- Research Funding (my institution, no personal gain): MSD, Verastem
- Clinical trials as PI/CI (my institution, no personal gain): Agalimmune/BioLineRx, AZ, BioNTech, Boston Pharmaceuticals, Corbus, Genentech, Grey Wolf Therapeutics, GSK, Incyte, Medannex, MSD, Nouscom, Nucana, Nuvectis, Pfizer, Roche, Salubris, Sapience, Scancell
Non-commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature
- University of Edinburgh – Employment
- Cancer Research UK – Employment
Last updated on 28th May 2025